がん疼痛管理の世界市場

がん疼痛管理の世界市場は2030年までに66億米ドルに達する

2024年に54億米ドルと推定されるがん疼痛管理の世界市場は、2024～2030年の分析期間においてCAGR 3.6%で成長し、2030年には66億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである急性疼痛タイプは、CAGR 2.8%を記録し、分析期間終了時には41億米ドルに達すると予測されます。慢性疼痛型セグメントの成長率は、分析期間中CAGR 4.9％と推定されます。

米国市場は15億米ドルと推定、中国はCAGR 6.5％で成長予測

米国のがん疼痛管理市場は2024年に15億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5％と2.7％と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界のがん疼痛管理市場- 主要動向と促進要因のまとめ

なぜがん疼痛管理は、あらゆるステージのがん治療において重要な要素なのか？

がん疼痛管理は、診断から治療、寛解、終末期医療に至るまで、患者に影響を及ぼし、腫瘍学において最も重要でありながら課題でもあります。他の多くの慢性疼痛とは異なり、がんに関連した疼痛は、腫瘍の組織への浸潤、神経の圧迫、治療の副作用、または併存する疾患から直接生じるなど、多因子にわたることがあります。検診や治療法の進歩によりがんの生存率が世界的に向上するにつれ、長生きする患者も増えているが、多くの場合、継続的な疼痛管理が必要な持続性疼痛やエピソード性疼痛を抱えています。痛みは患者のQOL、感情的な幸福、睡眠、機能的自立に大きく影響し、緩和されない痛みは抑うつ、不安、さらには治療プロトコルの遵守の低下につながる可能性があります。従って、効果的ながん疼痛管理は、単なる慰めではなく、包括的な腫瘍学的ケアの重要な要素です。現在、世界中の緩和ケアや支持療法の枠組みは、基礎疾患の治療と同様に疼痛緩和を重視しています。腫瘍内科医、緩和ケア医、薬剤師、看護師、心理士からなる集学的疼痛管理チームが、個々の患者に合ったケアプランを開発するために配備されるようになってきています。さらに、効果的な疼痛コントロールと、オピオイドやアジュバントによる依存や副作用の可能性とのバランスをとる必要性が、複雑さを増しています。ヘルスケアシステムがより人道的で患者中心のがん治療モデルを目指す中、疼痛管理は医療上の必要性だけでなく、倫理的で質の高いケアの指標としても注目されるようになってきています。

医薬品と技術の革新は、がん疼痛管理の選択肢をどのように高めているか？

技術的・薬学的進歩は、がんに関連した疼痛管理に利用できる手段を大幅に拡大しつつあります。従来の治療は、WHOの鎮痛薬ラダーに大きく依存してきました。このラダーには、軽度の痛みには非オピオイド、中等度の痛みには弱いオピオイド、重度の痛みには強いオピオイドが含まれます。しかし、現在ではこの枠組みを超えた、より的を絞った個別化されたアプローチによる技術革新が進んでいます。徐放性オピオイド製剤、経皮パッチ、舌下スプレー、頬錠は、薬物送達効率と患者のコンプライアンスを向上させています。従来のオピオイドに抵抗性を示すことが多い神経障害性疼痛は、抗けいれん薬、抗うつ薬、NMDA受容体拮抗薬などの補助薬で対処されることが多くなっています。さらに、カンナビノイドは、特に難治性の患者に対する補助療法として研究され、特定の地域では採用されています。技術面では、神経ブロック、硬膜外注射、脊髄刺激、髄腔内ドラッグデリバリーシステムなどの介入的疼痛管理技術が、複雑な症例や治療抵抗性の症例に選択肢を提供しています。デジタルヘルスプラットフォームやウェアラブルデバイスは、遠隔での疼痛モニタリングや服薬アドヒアランスに大きな役割を果たしており、臨床医がリアルタイムでレジメンを調整できるようになっています。AI主導のツールも開発されており、患者が報告する転帰や痛みのスコアを分析し、予測モデリングや精密な投薬に役立てています。遠隔医療は、特に地方や資源に乏しい環境にいる患者にとって、疼痛管理の継続性を可能にする重要な手段として台頭してきています。このような技術革新により、がん疼痛管理は、単に症状をコントロールするだけでなく、快適性、自律性、そして患者の全体的な経験を向上させることに焦点を当てた、反応的な分野から積極的な分野へと変貌を遂げつつあります。

がん疼痛管理の需要に影響を与えている患者層、ヘルスケア動向、政策要因は？

がん疼痛管理サービスに対する需要は、人口動態の変化、ヘルスケアシステムの改革、痛みや緩和ケアに対する社会的な考え方の変化によって、世界的に高まっています。先進国では、がんの罹患率が年齢と強く関連していることから、高齢化が進み、慢性疼痛や終末期疼痛の有病率が高まっています。一方、新興国では診断や治療へのアクセスが向上し、がんサバイバーや長期的な症状管理を必要とする患者が増加しています。また、基本的人権としての疼痛緩和に対する社会の認識も高まり、患者と介護者の双方がより包括的なケアソリューションを求めるようになっています。ヘルスケアプロバイダーはQOL指標を重視するようになり、統合的疼痛管理プログラムに対する制度的支援につながっています。さらに、多くの国々で、合法的な医療用途でのオピオイドの利用を改善するための国家政策が進展しており、規制への恐怖やスティグマによる治療不足という過去の動向に対抗しています。これにより、がん性疼痛におけるエビデンスに基づくオピオイド使用の新たな機会が開かれると同時に、乱用を防ぐための監視強化が求められています。これと並行して、保険償還の枠組みも調整され、集学的な疼痛治療サービス、介入手技、緩和医療相談がカバーされるようになり、より広範な導入が促されています。例えば、鍼治療、マッサージ、瞑想、音楽療法などの代替・補完療法は、疼痛コントロールの効果的な補助療法として認知されつつあります。低・中所得国では、地域に根ざした緩和ケアプログラムが台頭し、都市部の病院以外にも疼痛緩和サービスが広がっています。このように相互に関連する動向は、包括的で利用しやすく、文化的に配慮された、現代のヘルスケア目標に沿ったソリューションに対する世界の需要の高まりを裏付けています。

世界のがん疼痛管理の将来を形作る戦略的・臨床的動向とは？

がん疼痛管理市場の成長は、がん治療、患者の期待、ヘルスケアシステムの能力の変化を反映するいくつかの戦略的・臨床的動向によって牽引されています。大きな動向の一つは、個別化疼痛管理へのシフトであり、薬理ゲノミクスとバイオマーカー分析が鎮痛薬に対する患者の反応を予測し、それに応じて治療計画を調整するために使用されています。この精密なアプローチは、特に神経障害性疼痛や治療誘発性疼痛を伴う複雑な症例において、副作用を最小限に抑え、転帰を改善します。もう一つの重要な推進力は、疼痛管理を後期段階や緩和的介入としてではなく、最初からがん治療経路に組み込むことです。この積極的な戦略により、患者は継続的に評価され、サポートされることになり、がん治療へのアドヒアランスと全体的な予後が改善されます。集学的ケアチームの使用は、主要な腫瘍センターでは標準となりつつあり、腫瘍内科医、疼痛専門医、薬剤師、メンタルヘルス専門家による共同意思決定が重視されています。人工知能や機械学習ツールも電子カルテに組み込まれ、高リスク患者にフラグを立て、早期介入戦略を導くようになっています。公衆衛生の面では、WHOの緩和ケアロードマップや、必須鎮痛薬リスト拡大のための地域的取り組みのような世界的イニシアチブが、公平なアクセスのためのインフラを強化しています。一方、製薬会社は、有効性と安全性の二重の要請に応え、偏ったオピオイド作動薬や末梢作用薬など、乱用の可能性の低い次世代鎮痛薬に投資しています。また、遠隔医療や移動式ペインクリニックは、都市と農村の格差を埋め、十分なサービスを受けていない地域に拡張可能なソリューションを提供しています。これらの動向を合わせると、がん疼痛管理が、がんの旅全体にわたって、安心、尊厳、生活の向上を優先する、全人的で患者中心のケアモデルに深く組み込まれる未来が見えてくる。

セグメント

疼痛タイプ（急性疼痛タイプ、慢性疼痛タイプ）、薬物タイプ（オピオイド薬物タイプ、非オピオイド薬物タイプ、副腎皮質ホルモン薬物タイプ、抗うつ薬物タイプ、抗不安薬物タイプ、その他の薬物タイプ）、がんタイプ（肺がんタイプ、大腸がんタイプ、乳がんタイプ、前立腺がんタイプ、血液がんタイプ、その他のがんタイプ）、用途（免疫療法用途、化学療法用途、放射線療法用途、在宅療法用途、その他用途）、最終用途（病院最終用途、がん診療拠点病院最終用途、その他最終用途）

調査対象企業の例（注目の合計42社）

• AbbVie Inc.
• Apotex Inc.
• AstraZeneca PLC
• Bayer AG
• Daiichi Sankyo Co., Ltd.
• Eli Lilly and Company
• Endo International plc
• Esteve
• Grunenthal GmbH
• GW Pharmaceuticals
• Johnson & Johnson
• Medlab Clinical Ltd
• Mundipharma International Ltd.
• Orexo AB
• Panacea Biotec Ltd.
• Pfizer Inc.
• Purdue Pharma L.P.
• Sanofi S.A.
• Taiho Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Cancer Pain Management Market to Reach US$6.6 Billion by 2030

The global market for Cancer Pain Management estimated at US$5.4 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Acute Pain Type, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Chronic Pain Type segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 6.5% CAGR

The Cancer Pain Management market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Cancer Pain Management Market - Key Trends & Drivers Summarized

Why Is Cancer Pain Management a Critical Component of Oncological Care Across All Stages?

Cancer pain management remains one of the most vital yet challenging aspects of oncology, affecting patients across the continuum-from diagnosis through treatment, remission, and end-of-life care. Unlike many other forms of chronic pain, cancer-related pain can be multifactorial, arising directly from tumor invasion of tissues, nerve compression, treatment side effects, or comorbid conditions. As cancer survival rates improve globally due to advances in screening and therapeutics, an increasing number of patients are living longer but often with persistent or episodic pain that requires ongoing management. Pain significantly impacts a patient’s quality of life, emotional well-being, sleep, and functional independence, and unrelieved pain can lead to depression, anxiety, and even reduced adherence to treatment protocols. Effective cancer pain management is therefore not just a comfort measure but a critical component of comprehensive oncological care. Palliative and supportive care frameworks worldwide are now placing equal emphasis on pain relief as they do on treating the underlying disease. Multidisciplinary pain management teams-comprising oncologists, palliative care physicians, pharmacists, nurses, and psychologists-are increasingly being deployed to develop individualized care plans. Moreover, the need to balance effective pain control with the potential for dependency or side effects from opioids and adjuvants adds layers of complexity. As healthcare systems strive for more humane, patient-centric models of cancer treatment, pain management is gaining prominence not only as a medical necessity but also as a marker of ethical and quality care.

How Are Pharmaceutical and Technological Innovations Enhancing Cancer Pain Management Options?

Technological and pharmaceutical advancements are significantly expanding the arsenal of tools available for managing cancer-related pain. Traditional treatments have relied heavily on the WHO analgesic ladder, which includes non-opioids for mild pain, weak opioids for moderate pain, and strong opioids for severe pain. However, innovation is now driving beyond this framework with more targeted and personalized approaches. Extended-release opioid formulations, transdermal patches, sublingual sprays, and buccal tablets are improving drug delivery efficiency and patient compliance. Neuropathic pain, often resistant to traditional opioids, is increasingly being addressed with adjuvant medications like anticonvulsants, antidepressants, and NMDA receptor antagonists. Moreover, cannabinoids are being studied and adopted in certain jurisdictions as adjunctive therapies, particularly for patients with refractory symptoms. On the technological front, interventional pain management techniques such as nerve blocks, epidural injections, spinal cord stimulation, and intrathecal drug delivery systems are offering options for complex or treatment-resistant cases. Digital health platforms and wearable devices are playing a growing role in remote pain monitoring and medication adherence, allowing clinicians to adjust regimens in real time. AI-driven tools are also being developed to analyze patient-reported outcomes and pain scores, assisting in predictive modeling and precision dosing. Telemedicine has emerged as a critical enabler of continuity in pain management, especially for patients in rural or resource-limited settings. These innovations are transforming cancer pain management from a reactive to a proactive discipline-focused not just on controlling symptoms, but on enhancing comfort, autonomy, and overall patient experience.

What Patient Demographics, Healthcare Trends, and Policy Factors Are Influencing the Demand for Cancer Pain Management?

The demand for cancer pain management services is rising globally, driven by demographic shifts, healthcare system reforms, and changing societal attitudes toward pain and palliative care. Aging populations in developed nations, where cancer incidence is strongly age-related, are contributing to a higher prevalence of chronic and end-of-life pain cases. Meanwhile, improved access to diagnostics and treatment in emerging economies is creating a growing population of cancer survivors and patients who require long-term symptom management. Public awareness about pain relief as a basic human right has also increased, prompting both patients and caregivers to seek more comprehensive care solutions. Healthcare providers are now more focused on quality-of-life indicators, leading to institutional support for integrated pain management programs. Additionally, national policies are evolving in many countries to improve opioid availability for legitimate medical use, countering past trends of under-treatment due to regulatory fear or stigma. This has opened new opportunities for evidence-based opioid use in cancer pain, while simultaneously requiring tighter monitoring to prevent abuse. In parallel, reimbursement frameworks are being adjusted to cover multidisciplinary pain services, interventional procedures, and palliative consultations-thereby encouraging wider adoption. Cultural shifts are influencing treatment acceptance too; for example, alternative and complementary therapies like acupuncture, massage, meditation, and music therapy are gaining recognition as effective adjuncts in pain control. In low- and middle-income countries, the rise of community-based palliative care programs is helping extend pain relief services beyond urban hospitals. These interconnected trends underscore a rising global demand for comprehensive, accessible, and culturally sensitive cancer pain management solutions that align with modern healthcare objectives.

What Strategic and Clinical Trends Are Shaping the Future of Cancer Pain Management Globally?

The growth in the cancer pain management market is driven by several strategic and clinical trends that reflect the changing nature of cancer treatment, patient expectations, and healthcare system capacities. One major trend is the shift toward personalized pain management, where pharmacogenomics and biomarker analysis are used to predict patient response to analgesics and tailor treatment plans accordingly. This precision approach minimizes side effects and improves outcomes, particularly in complex cases involving neuropathic or treatment-induced pain. Another significant driver is the integration of pain management into cancer treatment pathways from the outset, rather than as a late-stage or palliative intervention. This proactive strategy ensures that patients are continuously evaluated and supported, improving adherence to cancer therapies and overall prognosis. The use of multidisciplinary care teams is becoming standard in leading oncology centers, emphasizing collaborative decision-making between oncologists, pain specialists, pharmacists, and mental health professionals. Artificial intelligence and machine learning tools are also being incorporated into electronic health records to flag high-risk patients and guide early intervention strategies. In terms of public health, global initiatives like the WHO’s palliative care roadmap and regional efforts to expand essential pain medication lists are strengthening infrastructure for equitable access. Meanwhile, pharmaceutical companies are investing in next-generation analgesics with lower abuse potential, such as biased opioid agonists and peripherally acting drugs, responding to the dual imperatives of efficacy and safety. Telehealth expansion and mobile pain clinics are also bridging the urban-rural divide, offering scalable solutions in underserved areas. Together, these trends point to a future where cancer pain management is deeply embedded in a holistic, patient-centered care model that prioritizes relief, dignity, and enhanced living across the cancer journey.

SCOPE OF STUDY:

The report analyzes the Cancer Pain Management market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Pain Type (Acute Pain Type, Chronic Pain Type); Drug Type (Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type, Other Drug Types); Cancer Type (Lung Cancer Type, Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types); Application (Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application, Other Applications); End-Use (Hospitals End-Use, Cancer Care Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AbbVie Inc.
• Apotex Inc.
• AstraZeneca PLC
• Bayer AG
• Daiichi Sankyo Co., Ltd.
• Eli Lilly and Company
• Endo International plc
• Esteve
• Grunenthal GmbH
• GW Pharmaceuticals
• Johnson & Johnson
• Medlab Clinical Ltd
• Mundipharma International Ltd.
• Orexo AB
• Panacea Biotec Ltd.
• Pfizer Inc.
• Purdue Pharma L.P.
• Sanofi S.A.
• Taiho Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Cancer Pain Management - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Cancer Burden Throws the Spotlight on Multimodal Pain Management Strategies
  • Increasing Focus on Quality of Life Accelerates Demand for Effective and Personalized Pain Relief Options
  • Expansion of Palliative Care Services Strengthens the Business Case for Integrated Cancer Pain Therapies
  • Growing Use of Opioids in Oncology Expands the Addressable Market Despite Regulatory Scrutiny
  • Advancements in Non-Opioid Analgesics and Adjunct Therapies Spur Innovation in Safer Pain Management Approaches
  • Patient-Centered Care Models Propel Growth in Tailored Pain Treatment Plans Across Cancer Stages
  • Breakthroughs in Targeted Drug Delivery Open New Vistas for Localized and Sustained Pain Relief
  • Integration of Digital Health and Remote Monitoring Drives Adoption of Personalized Pain Management Protocols
  • Rise in Neuropathic Pain Cases from Chemotherapy Enhances Demand for Adjuvant and Combination Therapies
  • Growing Acceptance of Cannabinoid-Based Therapies Generates Momentum in Alternative Pain Relief Options
  • Multidisciplinary Pain Clinics Sustain Growth in Comprehensive Cancer Care Networks
  • Aging Population and Longer Cancer Survival Rates Drive Long-Term Demand for Chronic Pain Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cancer Pain Management Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cancer Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cancer Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Cancer Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Acute Pain Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Acute Pain Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Acute Pain Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Pain Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Chronic Pain Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Chronic Pain Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Colorectal Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Colorectal Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Colorectal Cancer Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Breast Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Breast Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Breast Cancer Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Prostate Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Prostate Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Prostate Cancer Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Blood Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Blood Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Blood Cancer Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Lung Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Lung Cancer Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Lung Cancer Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Immunotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Immunotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Immunotherapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chemotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chemotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Chemotherapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Radiotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Radiotherapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Radiotherapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Home Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Home Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Home Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Cancer Care Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Cancer Care Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Cancer Care Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Opioid Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Opioid Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Opioid Drug Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Non-Opioids Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Non-Opioids Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Non-Opioids Drug Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Corticosteroids Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Corticosteroids Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Corticosteroids Drug Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Anti-depressants Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Anti-depressants Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: World 16-Year Perspective for Anti-depressants Drug Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Anti-Anxiety Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Anti-Anxiety Drug Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: World 16-Year Perspective for Anti-Anxiety Drug Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: World 16-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 71: USA Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: USA 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: USA 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 80: USA Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: USA Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: USA 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 83: USA Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: USA Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: USA 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Canada 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Canada 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 92: Canada Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Canada Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Canada 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 95: Canada Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Canada Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Canada 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 98: Canada Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Canada Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Canada 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• JAPAN
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Japan 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 104: Japan Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Japan Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Japan 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 107: Japan Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Japan Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Japan 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 110: Japan Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Japan Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Japan 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Japan Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Japan 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• CHINA
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 116: China Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: China 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 119: China Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: China Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: China 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 122: China Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: China Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: China 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 125: China Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: China Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: China 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 128: China Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: China Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: China 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• EUROPE
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Cancer Pain Management by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Europe 16-Year Perspective for Cancer Pain Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Europe 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Europe 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Europe Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Europe 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Europe 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Europe Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Europe 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• FRANCE
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 149: France Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: France 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: France 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 155: France Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: France Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: France 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 158: France Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: France Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: France 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 161: France Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: France Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: France 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• GERMANY
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Germany 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Germany 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Germany Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Germany 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 173: Germany Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Germany Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Germany 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 176: Germany Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Germany Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Germany 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Italy 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Italy 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 185: Italy Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Italy Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Italy 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 188: Italy Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Italy Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Italy 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 191: Italy Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Italy Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Italy 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 194: UK Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: UK 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 197: UK Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UK Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UK 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 200: UK Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UK Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: UK 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 203: UK Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: UK Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: UK 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 206: UK Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UK Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: UK 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Spain 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 212: Spain Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Spain Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Spain 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 215: Spain Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Spain Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Spain 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 218: Spain Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Spain Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Spain 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 221: Spain Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Spain Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Spain 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Russia 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 227: Russia Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Russia Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Russia 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 230: Russia Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Russia Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Russia 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 233: Russia Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Russia Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Russia 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 236: Russia Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Russia Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Russia 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Europe Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Europe 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Europe Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Europe 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Europe Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Europe Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Europe 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Europe Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Europe Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Europe 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Cancer Pain Management by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 16-Year Perspective for Cancer Pain Management by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Asia-Pacific Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Asia-Pacific 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 263: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Asia-Pacific Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Asia-Pacific 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Asia-Pacific Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Asia-Pacific 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 269: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Asia-Pacific Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Asia-Pacific 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Australia 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 275: Australia Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Australia Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Australia 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 278: Australia Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Australia Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Australia 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 281: Australia Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Australia Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Australia 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 284: Australia Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Australia Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Australia 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• INDIA
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 287: India Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: India 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 290: India Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: India Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: India 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 293: India Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: India Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: India 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 296: India Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: India Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: India 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 299: India Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: India Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: India 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: South Korea 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 305: South Korea Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: South Korea Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: South Korea 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 308: South Korea Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: South Korea Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: South Korea 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 311: South Korea Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: South Korea Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: South Korea 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 314: South Korea Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: South Korea Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: South Korea 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Asia-Pacific Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Asia-Pacific 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Asia-Pacific Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Asia-Pacific 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Asia-Pacific Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Asia-Pacific 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 329: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Asia-Pacific Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Rest of Asia-Pacific 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Cancer Pain Management by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Latin America 16-Year Perspective for Cancer Pain Management by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Latin America 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 338: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Latin America Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Latin America 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 341: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Latin America Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Latin America 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 344: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Latin America Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Latin America 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 347: Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Latin America Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Latin America 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Argentina 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 353: Argentina Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Argentina Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Argentina 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 356: Argentina Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Argentina Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Argentina 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 359: Argentina Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Argentina Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Argentina 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 362: Argentina Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Argentina Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Argentina 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Brazil 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 368: Brazil Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Brazil Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Brazil 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 371: Brazil Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Brazil Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Brazil 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 374: Brazil Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Brazil Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: Brazil 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 377: Brazil Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Brazil Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Brazil 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Mexico 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 383: Mexico Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Mexico Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Mexico 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 386: Mexico Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Mexico Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Mexico 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 389: Mexico Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Mexico Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Mexico 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 392: Mexico Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Mexico Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Mexico 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Latin America Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Latin America 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Latin America Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Latin America 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 404: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Latin America Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Latin America 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 407: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Latin America Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Rest of Latin America 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Cancer Pain Management by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 412: Middle East 16-Year Perspective for Cancer Pain Management by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 415: Middle East 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 416: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Middle East Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 418: Middle East 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 419: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Middle East Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 421: Middle East 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 422: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Middle East Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 424: Middle East 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 425: Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Middle East Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 427: Middle East 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 430: Iran 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 431: Iran Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Iran Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 433: Iran 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 434: Iran Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Iran Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 436: Iran 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 437: Iran Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Iran Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 439: Iran 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 440: Iran Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Iran Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 442: Iran 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 445: Israel 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 446: Israel Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Israel Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 448: Israel 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 449: Israel Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Israel Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 451: Israel 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 452: Israel Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Israel Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 454: Israel 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 455: Israel Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Israel Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 457: Israel 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Saudi Arabia Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 463: Saudi Arabia 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 464: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Saudi Arabia Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 466: Saudi Arabia 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 467: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Saudi Arabia Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 469: Saudi Arabia 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 470: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: Saudi Arabia Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 472: Saudi Arabia 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 475: UAE 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 476: UAE Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: UAE Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 478: UAE 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 479: UAE Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: UAE Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 481: UAE 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 482: UAE Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: UAE Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 484: UAE 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 485: UAE Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: UAE Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 487: UAE 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Rest of Middle East Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 493: Rest of Middle East 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 494: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Rest of Middle East Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 496: Rest of Middle East 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 497: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Rest of Middle East Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 499: Rest of Middle East 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 500: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Rest of Middle East Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 502: Rest of Middle East 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030
• AFRICA
  • Cancer Pain Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Cancer Pain Management by Pain Type - Acute Pain Type and Chronic Pain Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 505: Africa 16-Year Perspective for Cancer Pain Management by Pain Type - Percentage Breakdown of Value Sales for Acute Pain Type and Chronic Pain Type for the Years 2014, 2025 & 2030
  • TABLE 506: Africa Recent Past, Current & Future Analysis for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Africa Historic Review for Cancer Pain Management by Cancer Type - Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 508: Africa 16-Year Perspective for Cancer Pain Management by Cancer Type - Percentage Breakdown of Value Sales for Colorectal Cancer Type, Breast Cancer Type, Prostate Cancer Type, Blood Cancer Type, Other Cancer Types and Lung Cancer Type for the Years 2014, 2025 & 2030
  • TABLE 509: Africa Recent Past, Current & Future Analysis for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 510: Africa Historic Review for Cancer Pain Management by Application - Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 511: Africa 16-Year Perspective for Cancer Pain Management by Application - Percentage Breakdown of Value Sales for Immunotherapy Application, Chemotherapy Application, Radiotherapy Application, Home Therapy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 512: Africa Recent Past, Current & Future Analysis for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 513: Africa Historic Review for Cancer Pain Management by End-Use - Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 514: Africa 16-Year Perspective for Cancer Pain Management by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cancer Care Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 515: Africa Recent Past, Current & Future Analysis for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 516: Africa Historic Review for Cancer Pain Management by Drug Type - Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 517: Africa 16-Year Perspective for Cancer Pain Management by Drug Type - Percentage Breakdown of Value Sales for Opioid Drug Type, Non-Opioids Drug Type, Corticosteroids Drug Type, Anti-depressants Drug Type, Anti-Anxiety Drug Type and Other Drug Types for the Years 2014, 2025 & 2030

IV. COMPETITION